NEUROPACE, INC. Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
NEUROPACE, INC. (NPCE) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals of $1.98 million as of 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals · last filed 2026-03-03
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $1.98M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $1.40M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $1.63M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $1.18M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals |
|---|---|
| 2025-12-31 | $1.98M 10-K · filed 2026-03-03 |
| 2024-12-31 | $1.40M 10-K · filed 2026-03-03 |
| 2023-12-31 | $1.63M 10-K · filed 2025-03-04 |
| 2022-12-31 | $1.18M 10-K · filed 2024-03-05 |
| 2021-12-31 | $1.60M 10-K · filed 2023-03-02 |
| 2020-12-31 | $1.41M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |